# Clinical Trial to Treat Stage IV Cancer Patients

> **NCT06674538** · PHASE1 · ENROLLING_BY_INVITATION · sponsor: **Moonshot Antibodies** · enrollment: 12 (estimated)

## Conditions studied

- Soft Tissue Cancer

## Interventions

- **DRUG:** Moonshot antibodies

## Key facts

- **NCT ID:** NCT06674538
- **Lead sponsor:** Moonshot Antibodies
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-12-30
- **Primary completion:** 2027-01
- **Final completion:** 2029-01
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2025-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06674538

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06674538, "Clinical Trial to Treat Stage IV Cancer Patients". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT06674538. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*